News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,677 Results
Type
Article (15133)
Company Profile (116)
Press Release (362423)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (113015)
Career Advice (467)
Deals (18674)
Drug Delivery (41)
Drug Development (31472)
Employer Resources (51)
FDA (8851)
Job Trends (7714)
News (173551)
Policy (12466)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1338)
Accelerated approval (10)
Allergies (71)
Alliances (34967)
ALS (43)
Alzheimer's disease (630)
Antibody-drug conjugate (ADC) (180)
Approvals (9058)
Artificial intelligence (448)
Autoimmune disease (64)
Automation (31)
Bankruptcy (131)
Best Places to Work (6532)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (86)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (263)
Cancer (2199)
Cardiovascular disease (149)
Career advice (422)
Career pathing (9)
CAR-T (203)
CDC (8)
Cell therapy (496)
Cervical cancer (21)
Clinical research (26049)
Collaboration (1240)
Compensation (233)
Complete response letters (8)
COVID-19 (1226)
CRISPR (85)
C-suite (485)
Cystic fibrosis (60)
Data (2655)
Decentralized trials (1)
Denatured (26)
Depression (43)
Diabetes (215)
Diagnostics (5152)
Digital health (37)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (168)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (88)
Earnings (40637)
Editorial (9)
Employer branding (8)
Employer resources (46)
Events (53583)
Executive appointments (553)
FDA (10467)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (901)
Gene editing (171)
Generative AI (39)
Gene therapy (347)
GLP-1 (302)
Government (1283)
Grass and pollen (3)
Guidances (220)
Healthcare (9932)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1369)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (74)
Intellectual property (151)
Interviews (54)
IPO (8065)
IRA (10)
Job creations (1443)
Job search strategy (369)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (132)
Leadership (7)
Legal (2555)
Liver cancer (43)
Longevity (6)
Lung cancer (248)
Lymphoma (175)
Machine learning (34)
Management (18)
Manufacturing (527)
MASH (36)
Medical device (11847)
Medtech (11896)
Mergers & acquisitions (11249)
Metabolic disorders (405)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (122)
Neuropsychiatric disorders (19)
Neuroscience (1088)
NextGen: Class of 2026 (3555)
Non-profit (1537)
Now hiring (15)
Obesity (141)
Opinion (98)
Ovarian cancer (93)
Pain (105)
Pancreatic cancer (101)
Parkinson's disease (120)
Partnered (20)
Patents (302)
Patient recruitment (245)
Peanut (31)
People (33757)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase 1 (9591)
Phase 2 (11700)
Phase 3 (7584)
Pipeline (2590)
Policy (59)
Postmarket research (505)
Preclinical (4319)
Press Release (66)
Prostate cancer (96)
Psychedelics (6)
Radiopharmaceuticals (178)
Rare diseases (303)
Real estate (3407)
Recruiting (23)
Regulatory (10430)
Reports (20)
Research institute (1304)
Resumes & cover letters (71)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (163)
Series B (111)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2531)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (499)
Venture capital (43)
Weight loss (50)
Women's health (45)
Worklife (2)
Date
Today (63)
Last 7 days (312)
Last 30 days (1072)
Last 365 days (14754)
2026 (1487)
2025 (15066)
2024 (18720)
2023 (22121)
2022 (30836)
2021 (32558)
2020 (30574)
2019 (25854)
2018 (19504)
2017 (18896)
2016 (17799)
2015 (20608)
2014 (15242)
2013 (12839)
2012 (13862)
2011 (14145)
2010 (12921)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24944)
Australia (4326)
California (5309)
Canada (1678)
China (549)
Colorado (286)
Connecticut (235)
Delaware (107)
Europe (51120)
Florida (910)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (474)
India (34)
Indiana (264)
Iowa (8)
Japan (272)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (719)
Massachusetts (3569)
Michigan (275)
Minnesota (408)
Mississippi (4)
Missouri (99)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1567)
New Mexico (18)
New York (1425)
North Carolina (761)
North Dakota (9)
Northern California (2253)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1011)
Puerto Rico (19)
Rhode Island (34)
South America (515)
South Carolina (60)
South Dakota (1)
Southern California (2274)
Tennessee (103)
Texas (879)
United States (19808)
Utah (194)
Vermont (1)
Virginia (92)
Washington D.C. (18)
Washington State (516)
West Virginia (3)
Wisconsin (88)
Wyoming (1)
377,677 Results for "stemcell technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
November 11, 2025
·
3 min read
Press Releases
STEMCELL Technologies Announces Acquisition of Cellular Highways
June 2, 2025
·
3 min read
Press Releases
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries
June 27, 2025
·
1 min read
Deals
STEMCELL Technologies Announces Acquisition of Propagenix Inc.
STEMCELL Technologies is pleased to announce the acquisition of Propagenix Inc.
January 19, 2024
·
3 min read
Press Releases
Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies
October 7, 2025
·
4 min read
Press Releases
Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer
August 21, 2025
·
2 min read
STEMCELL Technologies Releases “Toward Sustainable Science” Report
STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report today.
October 11, 2023
·
3 min read
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company —a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them rather than using electricity.
February 29, 2024
·
3 min read
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award
STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada’s Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital.
November 24, 2023
·
3 min read
STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario.
October 26, 2023
·
3 min read
1 of 37,768
Next
